世界のネットワークポイントオブケア血糖検査の市場規模は、2023年に13億3,000万ドルと推定され、2024年から2030年にかけて4.4%のCAGRで成長すると予測されます。遠隔患者モニタリング (RPM)、データ駆動型の患者分析、高度なデータ転送技術の統合に対するニーズの高まりが、市場の拡大を推進する重要な要因の一つです。北アフリカと中東では、糖尿病の症例数が大幅に増加しています。さらに、国際糖尿病連合によると、インドでは2021年に7億4194万7000人の糖尿病患者が報告されています。このように、経済の急成長と糖尿病に対する意識の高まりが、糖尿病機器に大きな成長機会を生み出すと予想されます。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Network Point-of-Care Glucose Testing Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Network Point-of-Care Glucose Testing Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Network Point-of-Care Glucose Testing Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Network Point-of-Care Glucose Testing Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. i-STAT
4.3.1. i-STAT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Accu-Chek Inform II
4.4.1. Accu-Chek Inform II Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. StatStrip
4.5.1. StatStrip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. HemoCue
4.6.1. HemoCue Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. CareSens Expert Plus
4.7.1. CareSens Expert Plus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. BAROzen H Expert Plus
4.8.1. BAROzen H Expert Plus Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Network Point-of-Care Glucose Testing Market: Regional Estimates & Trend Analysis
5.1. Network Point-of-Care Glucose Testing Market Share, By Region, 2023 & 2030 (USD Million)
5.2. North America
5.2.1. North America Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.2. U.S.
5.2.2.1. U.S. Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.3. Canada
5.2.3.1. Canada Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.2.4. Mexico
5.2.4.1. Mexico Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3. Europe
5.3.1. Europe Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.2. UK
5.3.2.1. UK Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.3. Germany
5.3.3.1. Germany Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.4. France
5.3.4.1. France Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.5. Italy
5.3.5.1. Italy Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.6. Spain
5.3.6.1. Spain Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.7. Denmark
5.3.7.1. Denmark Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.8. Sweden
5.3.8.1. Sweden Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.3.9. Norway
5.3.9.1. Norway Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Asia Pacific
5.4.1. Asia Pacific Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.2. Japan
5.4.2.1. Japan Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.3. China
5.4.3.1. China Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.4. India
5.4.4.1. India Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.5. Australia
5.4.5.1. Australia Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.6. South Korea
5.4.6.1. South Korea Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4.7. Thailand
5.4.7.1. Thailand Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Latin America
5.5.1. Latin America Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.2. Brazil
5.5.2.1. Brazil Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5.3. Argentina
5.5.3.1. Argentina Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Middle East and Africa
5.6.1. Middle East and Africa Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.2. South Africa
5.6.2.1. South Africa Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.3. Saudi Arabia
5.6.3.1. Saudi Arabia Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.4. UAE
5.6.4.1. UAE Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6.5. Kuwait
5.6.5.1. Kuwait Network Point-of-Care Glucose Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis by Key Market Participants
6.2. Company Categorization
6.3. Company Heat Map Analysis
6.4. Company Profiles
6.4.1. Abbott, LLC
6.4.1.1. Participant’s Overview
6.4.1.2. Financial Performance
6.4.1.3. Product Benchmarking
6.4.1.4. Recent Developments/Strategic Initiatives
6.4.2. Nova Biomedical
6.4.2.1. Participant’s Overview
6.4.2.2. Financial Performance
6.4.2.3. Product Benchmarking
6.4.2.4. Recent Developments/Strategic Initiatives
6.4.3. Danaher
6.4.3.1. Participant’s Overview
6.4.3.2. Financial Performance
6.4.3.3. Product Benchmarking
6.4.3.4. Recent Developments/Strategic Initiatives
6.4.4. F. Hoffmann-La Roche Ltd.
6.4.4.1. Participant’s Overview
6.4.4.2. Financial Performance
6.4.4.3. Product Benchmarking
6.4.4.4. Recent Developments/Strategic Initiatives
6.4.5. Ascensia Diabetes Care Holdings AG.
6.4.5.1. Participant’s Overview
6.4.5.2. Financial Performance
6.4.5.3. Product Benchmarking
6.4.5.4. Recent Developments/Strategic Initiatives
6.4.6. Prodigy Diabetes Care, LLC
6.4.6.1. Participant’s Overview
6.4.6.2. Financial Performance
6.4.6.3. Product Benchmarking
6.4.6.4. Recent Developments/Strategic Initiatives
6.4.7. Nipro Corporation Japan
6.4.7.1. Participant’s Overview
6.4.7.2. Financial Performance
6.4.7.3. Product Benchmarking
6.4.7.4. Recent Developments/Strategic Initiatives
6.4.8. ACON Laboratories, Inc.
6.4.8.1. Participant’s Overview
6.4.8.2. Financial Performance
6.4.8.3. Product Benchmarking
6.4.8.4. Recent Developments/Strategic Initiatives
